We aimed to determine the efficacy of sacral neuromodulation (SNM) and affects on health-related quality of life in women.
Materials and Methods: The records of patients undergone SNM at Hacettepe University Hospital between 1999 and 2016 were analyzed. Female patients with a successful SNM procedure who were placed permanent battery were included the study. Both the SNM patients and the control group were administered the Turkish validated version of the Bristol Female Lower Urinary Tract Symptoms (BFLUTS) questionnaire and adapted to the scored form of BFLUTS.
Results: In total 35 patients had undergone SNM. Among these patients, a total of 19 female patients who had been tested successfully and were placed permanent batteries were sent a questionnaire and 9 women who answered the questionnaire were included in the study. The control group consisted of 18 female patients. The mean age of the SNM patients was 46.7±12.8 years, while the mean age of the control group was 44.2±8.2 years. There was no significant difference between the groups in terms of age (p=0.544). Filling and voiding symptoms were more frequent in the SNM patient group, whereas incontinence symptoms were similar in the SNM patients and control group. There was no deterioration in sexual function of SNM patients compared to controls. The quality of life of SNM patients was significantly lower than the control group.
Conclusion: SNM would be the choice of treatment for patients with lower urinary tract dysfunction. Urinary incontinence and sexual functions of female patients who underwent SNM treatment are similar to adults of the same age group.